Y. Antero Kesäniemi

ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)

Željko Reiner, Alberico L. Catapano, Guy De Backer et al. · European Heart Journal · 2011 · 3.5K citations · Full text

Medicine, Cardiology, Internal Medicine +17

New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk

Josée Dupuis, Claudia Langenberg, Inga Prokopenko et al. · Nature Genetics · 2010 · 2.2K citations · Full text

Life Sciences, Genetics, Molecular Genetics +17

Intensive Lipid Lowering with Simvastatin and Ezetimibe in Aortic Stenosis

Anne B. Rossebø, Terje R. Pedersen, Kurt Boman et al. · New England Journal of Medicine · 2008 · 1.6K citations · Full text

Medicine, Cardiology, Pharmacotherapy +17

Dose-response issues concerning physical activity and health: an evidence-based symposium

Y. Antero Kesäniemi, E. Danforth, Michael Dam Jensen et al. · Medicine & Science in Sports & Exercise · 2001 · 841 citations

Public Health, Health Behavior, Preventive Medicine +8

Low Plasma Ghrelin Is Associated With Insulin Resistance, Hypertension, and the Prevalence of Type 2 Diabetes

Seppo Pöykkö, Eija Kellokoski, Sohvi Hörkkö et al. · Diabetes · 2003 · 521 citations · Full text

Medicine, Endocrinology, Molecular Medicine +12